alpha-aminopyridine has been researched along with Amphetamine-Related Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, JJ; Deveau, CM; Kline, H; Yamamoto, BK | 1 |
| Harrison, AA; Liem, YT; Markou, A | 1 |
2 other study(ies) available for alpha-aminopyridine and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Roflumilast treatment during forced abstinence reduces relapse to methamphetamine seeking and taking.
Topics: Aminopyridines; Amphetamine-Related Disorders; Animals; Benzamides; Central Nervous System Stimulants; Cyclopropanes; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; Phosphodiesterase 4 Inhibitors; Rats; Recurrence; Self Administration | 2022 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; Disease Models, Animal; Drug Combinations; Electric Stimulation; Fluoxetine; Male; Mecamylamine; Neurons; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Wistar; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2001 |